I C U Medical Inc (ICUI) Stock Price, Quote & News

Company Profile

ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. It offers infusion therapy products, such as needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoLock closed system transfer devices and ChemoClaveTM for preparation and administration of hazardous drugs; Tego needle free connectors; Deltec GRIPPER...

Industry: Medical Instruments & Supplies

Sector: Healthcare

Phone: 949 366 2183

Fax: 949 366 8368

Website: www.icumed.com

Address:

951 Calle Amanecer, San Clemente, United States

erevnon Feb. 20 at 12:20 PM

Piper Sandler maintains ICU Medical $ICUI at Overweight and raises the price target from $172 to https://marketsblock.com/stock-upgrades-and-downgrades/

0 · Reply

StocktwitsEarnings Feb. 19 at 9:16 PM

$ICUI Q4 '25 Earnings Results & Recap • Reported GAAP EPS of -$0.64 up 34.02% YoY • Reported revenue of $540.7M down -14.15% YoY • For fiscal year 2026, ICU Medical estimates GAAP net income between $26M and $44M, with GAAP EPS from $1.03 to $1.74. Adjusted EBITDA is projected from $400M to $430M.

0 · Reply

StocktwitsEarnings Feb. 19 at 9:16 PM

$ICUI Q4 '25 Earnings Results & Recap • Reported GAAP EPS of -$0.64 up 34.02% YoY • Reported revenue of $540.7M down -14.15% YoY • For fiscal year 2026, ICU Medical estimates GAAP net income between $26M and $44M, with GAAP net earnings per share from $1.03 to $1.74. The company expects adjusted EBITDA between $400M and $430M, and adjusted EPS from $7.75 to $8.45.

0 · Reply

Oratory Feb. 19 at 4:24 PM

$ICUI Reporting early, which is usually a good sign.

0 · Reply

Estimize Feb. 19 at 4:00 PM

$ICUI reports after the close, Estimize Consensus +0.10 EPS and +10.51M Revs compared to WS http://www.estimize.com/icui/fq4-2025?utm_conte

0 · Reply

BillionerOfKing Feb. 10 at 11:48 AM

$ICUI Current Stock Price: $151.72 Contracts to trade: $150.0 ICUI Feb 20 2026 Call Entry: $7.65 Exit: $10.32 ROI: 35% Hold ~30 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts

0 · Reply

AxiomAssets Feb. 4 at 9:13 AM

$ICUI medical devices, hospital capital spending

0 · Reply

Estimize Jan. 19 at 2:01 PM

Wall St is expecting 1.69 EPS for $ICUI Q4 [Reporting 03/04 AMC] http://www.estimize.com/intro/icui?chart=historical&metric_name=eps&utm_co

0 · Reply

Estimize Jan. 5 at 2:00 PM

Wall St is expecting 1.69 EPS for $ICUI Q4 [Reporting 03/04 AMC] http://www.estimize.com/intro/icui?chart=historical&metric_name=eps&utm_co

0 · Reply

VinylVow Dec. 27 at 12:49 PM

$ICUI Investors are weighing durability against tactical noise; free‑cash‑flow conversion needs to normalize — stable fundamentals would matter more than macro swings. Markets will follow data, not narratives.

0 · Reply

ICU Medical, Inc. (ICUI) Q4 2025 Earnings Call Transcript

Feb 19, 2026, 4:05 PM EST - 19 hours ago

ICU Medical Announces Fourth Quarter 2025 Results and Provides Fiscal Year 2026 Guidance

Feb 5, 2026, 8:30 AM EST - 15 days ago

ICU Medical Announces Time of Fourth Quarter 2025 Earnings Conference Call

Jan 14, 2026, 6:25 PM EST - 5 weeks ago

ICU Medical, Inc. (ICUI) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Dec 31, 2025, 8:30 AM EST - 7 weeks ago

ICU Medical to Present at the 44th Annual J.P. Morgan Healthcare Conference

Dec 30, 2025, 5:31 PM EST - 7 weeks ago

ICU Medical: Difficult Transition, A More Interesting Company (Upgrade)

Nov 20, 2025, 8:30 AM EST - 3 months ago

ICU Medical to Participate at the Piper Sandler 37th Annual Healthcare Conference

Nov 6, 2025, 7:46 PM EST - 3 months ago

ICU Medical, Inc. (ICUI) Q3 2025 Earnings Call Transcript

Nov 6, 2025, 4:05 PM EST - 3 months ago

ICU Medical Announces Third Quarter 2025 Results and Updates its Fiscal Year 2025 Guidance

Oct 23, 2025, 8:30 AM EDT - 4 months ago

ICU Medical Announces Time of Third Quarter 2025 Earnings Conference Call

Sep 10, 2025, 11:04 AM EDT - 5 months ago

ICU Medical, Inc. (ICUI) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

Aug 21, 2025, 8:30 AM EDT - 6 months ago

ICU Medical to Participate in Upcoming Investor Conferences

Aug 10, 2025, 1:03 AM EDT - 6 months ago

ICU Medical, Inc. (ICUI) Q2 2025 Earnings Call Transcript

Aug 7, 2025, 4:05 PM EDT - 7 months ago

ICU Medical Announces Second Quarter 2025 Results and Updates its Fiscal Year 2025 Guidance

Jul 24, 2025, 8:30 AM EDT - 7 months ago

ICU Medical Announces Time of Second Quarter 2025 Earnings Conference Call

May 10, 2025, 12:13 PM EDT - 10 months ago

ICU Medical, Inc. (ICUI) Q1 2025 Earnings Call Transcript

May 9, 2025, 10:00 AM EDT - 10 months ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against ICU Medical, Inc. (ICUI) And Encourages Shareholders to Reach Out

May 8, 2025, 5:30 PM EDT - 10 months ago

ICU Medical, Inc. Investigated For Securities Fraud; Block & Leviton Encourages Investors Who Have Lost Money to Contact the Firm

May 8, 2025, 4:05 PM EDT - 10 months ago

ICU Medical Announces First Quarter 2025 Results

May 8, 2025, 10:00 AM EDT - 10 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against ICU Medical, Inc. (ICUI) and Encourages Shareholders to Learn More About the Investigation

May 7, 2025, 10:00 AM EDT - 10 months ago

ICU Medical, Inc. (ICUI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation

May 6, 2025, 10:00 AM EDT - 10 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages ICU Medical, Inc. (ICUI) Shareholders to Inquire about Securities Investigation

May 5, 2025, 10:00 AM EDT - 10 months ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating ICU Medical, Inc. (ICUI) And Encourages Investors to Connect

May 4, 2025, 10:00 AM EDT - 10 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages ICU Medical, Inc. (ICUI) Stockholders to Inquire about Securities Investigation

May 2, 2025, 10:00 AM EDT - 10 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against ICU Medical, Inc. (ICUI) and Encourages Investors to Learn More About the Investigation

May 1, 2025, 10:00 AM EDT - 10 months ago

ICU Medical, Inc. (ICUI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation

May 1, 2025, 8:30 AM EDT - 10 months ago

ICU Medical, Inc. and Otsuka Pharmaceutical Factory, Inc. Complete Joint Venture to Bolster IV Solutions Manufacturing and Innovation in North America

Apr 30, 2025, 10:00 AM EDT - 10 months ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against ICU Medical, Inc. (ICUI) And Encourages Stockholders to Reach Out

Apr 29, 2025, 10:00 AM EDT - 10 months ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating ICU Medical, Inc. (ICUI) And Encourages Stockholders to Connect

Apr 28, 2025, 10:00 AM EDT - 10 months ago

ICU Medical, Inc. (ICUI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation

Apr 28, 2025, 9:02 AM EDT - 10 months ago

ICUI Investors Have Opportunity to Join ICU Medical, Inc. Fraud Investigation with the Schall Law Firm

Apr 24, 2025, 8:30 AM EDT - 10 months ago

ICU Medical Announces Time of First Quarter 2025 Earnings Conference Call

Apr 7, 2025, 8:00 AM EDT - 11 months ago

ICU Medical Introduces Its New Category of Infusion Devices With FDA Clearances of Plum Solo™ and Plum Duo™ Precision IV Pumps

Mar 24, 2025, 8:30 AM EDT - 11 months ago

ICU Medical to Present at the 24th Annual Needham Virtual Healthcare Conference

Mar 7, 2025, 8:40 AM EST - 1 year ago

ICU Medical to Participate at the KeyBanc Healthcare Forum

Feb 27, 2025, 10:57 PM EST - 1 year ago

ICU Medical, Inc. (ICUI) Q4 2024 Earnings Call Transcript

Feb 27, 2025, 4:05 PM EST - 1 year ago

ICU Medical Announces Fourth Quarter 2024 Results and Provides Fiscal Year 2025 Guidance

Feb 13, 2025, 4:05 PM EST - 1 year ago

ICU Medical Announces Time of Fourth Quarter 2024 Earnings Conference Call

erevnon Feb. 20 at 12:20 PM

Piper Sandler maintains ICU Medical $ICUI at Overweight and raises the price target from $172 to https://marketsblock.com/stock-upgrades-and-downgrades/

0 · Reply

StocktwitsEarnings Feb. 19 at 9:16 PM

0 · Reply

StocktwitsEarnings Feb. 19 at 9:16 PM

$ICUI Q4 '25 Earnings Results & Recap • Reported GAAP EPS of -$0.64 up 34.02% YoY • Reported revenue of $540.7M down -14.15% YoY • For fiscal year 2026, ICU Medical estimates GAAP net income between $26M and $44M, with GAAP net earnings per share from $1.03 to $1.74. The company expects adjusted EBITDA between $400M and $430M, and adjusted EPS from $7.75 to $8.45.

0 · Reply

Oratory Feb. 19 at 4:24 PM

$ICUI Reporting early, which is usually a good sign.

0 · Reply

Estimize Feb. 19 at 4:00 PM

$ICUI reports after the close, Estimize Consensus +0.10 EPS and +10.51M Revs compared to WS http://www.estimize.com/icui/fq4-2025?utm_conte

0 · Reply

BillionerOfKing Feb. 10 at 11:48 AM

0 · Reply

AxiomAssets Feb. 4 at 9:13 AM

$ICUI medical devices, hospital capital spending

0 · Reply

Estimize Jan. 19 at 2:01 PM

Wall St is expecting 1.69 EPS for $ICUI Q4 [Reporting 03/04 AMC] http://www.estimize.com/intro/icui?chart=historical&metric_name=eps&utm_co

0 · Reply

Estimize Jan. 5 at 2:00 PM

Wall St is expecting 1.69 EPS for $ICUI Q4 [Reporting 03/04 AMC] http://www.estimize.com/intro/icui?chart=historical&metric_name=eps&utm_co

0 · Reply

VinylVow Dec. 27 at 12:49 PM

0 · Reply

AberrationArc Dec. 25 at 5:03 PM

$ICUI The setup offers potential, but only if discipline accelerates faster than complexity. Competitive differentiation needs clearer proof points. Investors are likely to reward clarity more than ambition. In short, this remains an execution‑driven story with meaningful but conditional upside.

0 · Reply

JarvisFlow Dec. 16 at 5:30 PM

Raymond James has updated their rating for ICU Medical ( $ICUI ) to Strong Buy with a price target of 197.

0 · Reply

BillionerOfKing Dec. 10 at 9:52 PM

$ICUI Current Stock Price: $147.59 Contracts to trade: $150 ICUI Dec 19 2025 Call Entry: $2.30 Exit: $4.16 ROI: 81% Hold ~28 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts

0 · Reply

Noname2022 Nov. 29 at 1:46 PM

$CRMD $FMS $DVA $ICUI

1 · Reply

Noname2022 Nov. 29 at 1:26 PM

$CRMD $DVA $FMS $ICUI Clearguard HD caps used in 40 Fresenius facilities https://www.ajkd.org/article/s0272-6386%2816%2930519-4/

1 · Reply

Noname2022 Nov. 29 at 1:18 PM

$CRMD $ICUI $DVA $FMS Impact of using Clearguard HD caps at HCA inpatient (largest private hospital) https://2024apic.eventscribe.net/fsPopup.asp?PosterID=668778&mode=posterInfo

1 · Reply

Noname2022 Nov. 29 at 1:08 PM

$CRMD $DVA $ICUI https://www.asn-online.org/education/kidneyweek/2020/program-abstract.aspx?controlId=3442083 Impact of implementing Clearguard HD caps at Davita (2018)

0 · Reply

SuperGreenToday Nov. 12 at 5:13 PM

$ICUI Share Price: $140.60 Contract Selected: May 15, 2026 $120 Calls Buy Zone: $25.75 – $31.82 Target Zone: $41.87 – $51.18 Potential Upside: 54% ROI Time to Expiration: 183 Days | Updates via https://fxcapta.com/stockinfo/

0 · Reply

JarvisFlow Nov. 7 at 2:46 PM

Keybanc updates rating for ICU Medical ( $ICUI ) to Overweight, target set at 173 → 175.

0 · Reply

JarvisFlow Nov. 7 at 12:50 PM

Piper Sandler has adjusted their stance on ICU Medical ( $ICUI ), setting the rating to Overweight with a target price of 153 → 172.

0 · Reply

d_risk Nov. 7 at 12:48 AM

$ICUI - ICU Medical Inc. Common Stock - 10Q - Updated Risk Factors ICUI flags new risks from rising U.S. tariffs on imports from Costa Rica and Mexico, with a national security probe under Section 232 threatening USMCA exemptions and potentially driving up costs. #MedicalDevices #NationalSecurity #SupplyChainCosts #USMCARisks #TradeTariffs 🟢 Added 🟠 Removed https://d-risk.ai/ICUI/10-Q/2025-11-06

0 · Reply

GoodTidings Nov. 4 at 10:55 PM

$ICUI really think Schlorffer should go... Every CEO who R/S ore intends to R/S more than once is not competent for the job... Instead of focusing on increasing sales and onboarding Hospitals this guy is shitting about a vote for R)S... The guy should be ashamed of himself... The easy way out... Screwing shareholders... That's not what shareholders pay for a salary of almost $50000 per month...

0 · Reply

Market Cap	3.74B
Revenue (ttm)	2.38B
Net Income (ttm)	-117.69M
EPS (ttm)	N/A
PE Ratio	23.24
Forward PE	22.98
Profit Margin	-4.94%
Debt to Equity Ratio	0.62

Volume	550,300
Avg Vol	238,122
Day's Range	N/A - N/A
Shares Out	24.69M
Stochastic %K	72%
Beta	0.79
Analysts	Strong Sell
Price Target	$181.40